Editorial Director Rita Peters interviews Alan Fisher of Dycem about risk management is applied to contamination control for pharmaceutical manufacturing
Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Alan Fisher of Dycem. They discuss how risk management can be applied to contamination control for pharmaceutical manufacturing and how risk can be measured. The discussion also covered the standards or practices that should guide facility operators in developing risk management strategies and the special risks facilities, particularly contract manufacturing operations, may may face and these risks might be mitigated.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.